Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001490978-25-000091
Filing Date
2025-06-20
Accepted
2025-06-20 16:36:31
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750451757.html 4  
1 FORM 4 wk-form4_1750451757.xml 4 6035
  Complete submission text file 0001490978-25-000091.txt   7485
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SYNERGY PHARMACEUTICALS INC. 420 LEXINGTON AVE NEW YORK NY 10020
Business Address
Sender Gary (Reporting) CIK: 0001659085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 251061970